Quiz
10 Questions
0 Views

Quiz

Created by
@InsightfulForethought

Podcast Beta

Play an AI-generated podcast conversation about this lesson

Questions and Answers

Which antibody has been shown to prolong overall survival in physically fit patients with previously untreated chronic lymphocytic leukemia (CLL)?

  • Obinutuzumab
  • Chlorambucil
  • Rituximab (correct)
  • GA101
  • What is the primary end point of the study?

  • Response rate
  • Overall survival
  • Adverse events
  • Investigator-assessed progression-free survival (correct)
  • What is the range of the Cumulative Illness Rating Scale (CIRS)?

  • 0 to 10
  • 0 to 56 (correct)
  • 0 to 20
  • 0 to 40
  • What is the median age of the patients in the study?

    <p>73 years</p> Signup and view all the answers

    What is the estimated creatinine clearance of the patients in the study?

    <p>50 to 69 ml per minute</p> Signup and view all the answers

    Which antibody was investigated in this study as compared to rituximab, each combined with chlorambucil, in patients with previously untreated CLL and coexisting conditions?

    <p>Obinutuzumab</p> Signup and view all the answers

    What was the primary end point of the study?

    <p>Progression-free survival</p> Signup and view all the answers

    What was the median age of the patients in the study?

    <p>73 years</p> Signup and view all the answers

    What was the range of the Cumulative Illness Rating Scale (CIRS)?

    <p>0 to 56</p> Signup and view all the answers

    What was the estimated creatinine clearance of the patients in the study?

    <p>30 to 69 ml per minute</p> Signup and view all the answers

    More Like This

    Quiz
    5 questions
    Quiz de Pisco
    5 questions

    Quiz de Pisco

    LuxuriantMeadow avatar
    LuxuriantMeadow
    Use Quizgecko on...
    Browser
    Browser